All News about Gilead Sciences
From Arcus Biosciences
Via Business Wire
Via Benzinga
Preview: Gilead Sciences's Earnings
February 05, 2024
Via Benzinga
Ted Love, MD, Joins Gilead Sciences’ Board of Directors
February 01, 2024
Via Business Wire
Behind the Scenes of Gilead Sciences's Latest Options Trends
January 25, 2024
Via Benzinga
Via Benzinga
Exposures
Product Safety
S&P 500, Dow Extend All-Time Highs: 'It's A Lot Of Fun For Stock Investors While It Lasts,' Wall Street Veteran Says
January 22, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Dow Gains Over 100 Points; Archer-Daniels-Midland Shares Plunge
January 22, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
S&P 500, Nasdaq, Dow Jones Strike All-Time Highs Ahead Of Key Earnings This Week: What's Driving Markets Monday?
January 22, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
10 Health Care Stocks Whale Activity In Today's Session
January 22, 2024
Via Benzinga
Gilead Provides Update on Phase 3 EVOKE-01 Study
January 22, 2024
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free